We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $748M
1-Year Est. Return 27.21%
This Fund
S&P 500
This Quarter Est. Return
+1.7%
1 Year Est. Return
+27.21%
3 Year Est. Return
+69.53%
5 Year Est. Return
+110.76%
10 Year Est. Return
AUM
$353M
AUM Growth
-$38.5M
Cap. Flow
-$19.5M
Cap. Flow %
-5.52%
Top 10 Hldgs %
29.86%
Holding
76
New
2
Increased
32
Reduced
37
Closed
5

Top Buys

Rank Stock Value
1
CLB icon
Core Laboratories
CLB
+$2.04M
2
VSTO
Vista Outdoor Inc.
VSTO
+$1.95M
3
CL icon
Colgate-Palmolive
CL
+$536K
4
ROL icon
Rollins
ROL
+$529K
5
DHR icon
Danaher
DHR
+$529K

Top Sells

Rank Stock Value
1
TTC icon
Toro Company
TTC
+$9.03M
2
AMGN icon
Amgen
AMGN
+$8.9M
3
AON icon
Aon
AON
+$1.61M
4
KDP icon
Keurig Dr Pepper
KDP
+$1.5M
5
DLX icon
Deluxe
DLX
+$1.35M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.36%
2 Industrials 19.1%
3 Technology 16.87%
4 Healthcare 16.8%
5 Consumer Staples 13.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKC icon
1
McCormick & Company Non-Voting
MKC
$14B
$13.7M 3.87%
256,270
-12,038
-4% -$588K
MA icon
2
Mastercard
MA
$507B
$11.9M 3.37%
134,992
-27
-0% -$2.58K
BCR
3
DELISTED
CR Bard Inc.
BCR
$11M 3.11%
46,702
-2,052
-4% -$446K
TTC icon
4
Toro Company
TTC
$8.83B
$10.4M 2.96%
236,976
-206,812
-47% -$9.03M
ACN icon
5
Accenture
ACN
$114B
$9.88M 2.8%
87,223
-998
-1% -$116K
GILD icon
6
Gilead Sciences
GILD
$187B
$9.79M 2.77%
117,323
-7,169
-6% -$636K
NEU icon
7
NewMarket
NEU
$8.14B
$9.77M 2.77%
23,586
-2,143
-8% -$864K
ORCL icon
8
Oracle
ORCL
$457B
$9.74M 2.76%
238,044
+2,205
+0.9% +$88K
CTSH icon
9
Cognizant
CTSH
$28.1B
$9.74M 2.76%
170,099
-113
-0.1% -$6.83K
SEIC icon
10
SEI Investments
SEIC
$13.2B
$9.47M 2.68%
196,906
-9,112
-4% -$439K
MSFT icon
11
Microsoft
MSFT
$3.71T
$9.01M 2.55%
175,992
+4,172
+2% +$217K
APH icon
12
Amphenol
APH
$204B
$8.98M 2.55%
1,253,400
-17,952
-1% -$129K
ROST icon
13
Ross Stores
ROST
$73.7B
$8.7M 2.47%
153,541
+7,157
+5% +$397K
GGG icon
14
Graco
GGG
$12.6B
$8.56M 2.43%
325,269
-12,729
-4% -$342K
KDP icon
15
Keurig Dr Pepper
KDP
$44.3B
$8.55M 2.42%
88,531
-16,300
-16% -$1.5M
AAPL icon
16
Apple
AAPL
$4.67T
$8.53M 2.42%
356,960
-5,424
-1% -$135K
TJX icon
17
TJX Companies
TJX
$145B
$8.4M 2.38%
217,552
-15,052
-6% -$575K
ROL icon
18
Rollins
ROL
$17.3B
$8.36M 2.37%
643,014
+43,114
+7% +$529K
PEP icon
19
PepsiCo
PEP
$188B
$8.27M 2.34%
78,036
-4,999
-6% -$516K
CBRL icon
20
Cracker Barrel
CBRL
$1.22B
$8.16M 2.31%
47,569
-3,228
-6% -$504K
CPRT icon
21
Copart
CPRT
$31.2B
$7.9M 2.24%
1,288,976
-36,904
-3% -$207K
DLTR icon
22
Dollar Tree
DLTR
$24.7B
$7.54M 2.14%
80,038
+1,745
+2% +$148K
NKE icon
23
Nike
NKE
$57B
$7.45M 2.11%
134,958
-1,253
-0.9% -$71.4K
GPN icon
24
Global Payments
GPN
$24.5B
$6.99M 1.98%
97,974
-9,842
-9% -$726K
AME icon
25
Ametek
AME
$54.5B
$6.33M 1.79%
137,002
+1,231
+0.9% +$59.2K

Similar funds

JLB & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, JLB & Associates held 76 positions worth $353M, down 9.8% from $391M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

JLB & Associates withdrew a net $19.5M in Q2 2016, closing 5 positions and reducing 37 holdings. Its most notable exit was Amgen, an estimated $8.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

Against the trend, JLB & Associates opened a new position in Core Laboratories worth $2.09M.

  • JLB & Associates's largest Q2 2016 buy was Core Laboratories: 16,873 shares worth $2.09M.
  • JLB & Associates added most to Vista Outdoor Inc. in Q2 2016, an estimated $1.95M increase.
  • JLB & Associates's biggest Q2 2016 reduction was Toro Company, cutting an estimated $9.03M.
  • JLB & Associates fully exited Amgen in Q2 2016, selling an estimated $8.9M.
  • JLB & Associates's ten largest holdings make up 30% of its $353M portfolio in Q2 2016.
  • JLB & Associates opened 2 new positions and closed 5 in Q2 2016.
  • JLB & Associates's portfolio value fell 9.8% quarter-over-quarter to $353M.

Based on JLB & Associates's 13F filing for Q2 2016, filed 21 Jul 2016.